Robert W. Baird Cuts Agilent Technologies (NYSE:A) Price Target to $159.00

Agilent Technologies (NYSE:A) had its price target reduced by equities researchers at Robert W. Baird from $161.00 to $159.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the medical research company’s stock. Robert W. Baird’s target price would suggest a potential upside of 18.21% from the stock’s previous close.

Other equities analysts have also issued reports about the stock. Citigroup boosted their price target on shares of Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. JPMorgan Chase & Co. cut their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. Finally, Sanford C. Bernstein cut their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday, November 26th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $146.15.

Agilent Technologies Trading Up 0.2 %

Shares of Agilent Technologies stock opened at $134.51 on Thursday. The stock has a market cap of $38.37 billion, a PE ratio of 30.43, a price-to-earnings-growth ratio of 3.63 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The firm has a fifty day moving average price of $140.90 and a 200 day moving average price of $139.28. Agilent Technologies has a 1 year low of $124.16 and a 1 year high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The company had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. Equities research analysts predict that Agilent Technologies will post 5.56 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This represents a 4.60 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Institutional Trading of Agilent Technologies

Several institutional investors and hedge funds have recently bought and sold shares of A. CKW Financial Group raised its position in Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 100 shares during the last quarter. Global X Japan Co. Ltd. raised its position in Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after buying an additional 116 shares during the last quarter. Redwood Park Advisors LLC purchased a new position in Agilent Technologies during the 4th quarter worth $27,000. Lee Danner & Bass Inc. purchased a new position in Agilent Technologies during the 4th quarter worth $29,000. Finally, Sunbelt Securities Inc. raised its position in Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock worth $30,000 after buying an additional 192 shares during the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.